In the first part of a two-part series, Ann Harrison interviews addiction treatment expert Dr. Howard Kornfeld about the FDA decision to reject the Lykos Therapeutics proposal for MDMA-assisted therapy.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
In the wake of the FDA's rejection of its proposed MDMA-assisted therapy for PTSD, Lykos Therapeutics laid off approximately 100 employees and appointed new leadership while the MAPS nonprofit cut 33% of its workforce.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
Prior to last week's FDA decision to reject Lykos Therapeutics' proposed MDMA-assisted therapy for PTSD, Rep. Jack Bergman (R-MI) reflected on the urgent need for better PTSD treatments to reduce veteran suicides and the game plan for lawmakers to keep support for psychedelic-assisted therapies moving forward.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
FDA taps the brakes on MDMA therapy approval, requesting additional evidence to ensure safety and efficacy for PTSD treatment.| Synergetic Press
